Table 3.

Clinical trials of electrospun scaffolds.

Study	Status	Condition/disease	Aim	Number of participants	Scaffold	Results
Experimental study of the vascular prosthesis manufactured by electrospinning (NCT02255188)	Completed	Arterial occlusive disease	Determination of the safety of electrospun vascular grafts for the development of thrombosis.	120	PCL grafts; PCL/gelatin grafts; PLGA/PCL/gelatin grafts; Nylon 6 grafts.	Not currently available
EktoTherix™ regenerative tissue scaffold for repair of surgical excision wounds (NCT02409628)	Completed	Non-melanoma skin cancer; Basal cell carcinoma; Squamous cell carcinoma	Assessment of the safety and performance of EktoTherix™ Tissue Repair Scaffold for the treatment of full-thickness, dermatologic wounds due to the surgical removal of non-melanoma skin cancers.	12	EktoTherix™ Tissue Repair Scaffold:	Not currently available
Clinical trial for the treatment of diabetic foot ulcers using a nitric oxide releasing patch: PATHON	Completed	Diabetic foot	Evaluation of the effectiveness and safety of nitric oxide releasing wound dressings for the treatment of diabetic foot ulcers.	100	Multilayer polymeric transdermal patch with a continuous release of nitric oxide (polyurethane-based fibers).	Not currently available
Controlled nitric oxide releasing patch vs. meglumine antimoniate in the treatment of cutaneous Leishmaniasis	Terminated	Cutaneous Leishmaniasis	Evaluation of the effectiveness of a nitric oxide topical donor for the treatment of cutaneous leishmaniasis.	178	Multilayer polymeric transdermal patch with a continuous release of nitric oxide (polyurethane-based fibers).	Not currently available

The data are obtained from ClinicalTrials.gov, a resource provided by the U.S. National Library of Medicine (Accessed on September 2018).